Work

Abstract P5-04-21: FGFR4 is a novel druggable target for recurrent ER-positive breast cancers

Year: 2019

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs18-p5-04-21

Authors: KM Levine, K Ding, N Priedigkeit, MJ Sikora, N Tasdemir, L Zhu, GC Tseng, RC Jankowitz, DJ Dabbs, PF McAuliffe, AV Lee, S Oesterreich

Institutions: University of Pittsburgh, University of Colorado Denver

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2944372427

Cites:

Cited by:

Related to: 10